IMVT earnings: a negative outcome, -8.2%

On June 8, 2022, Immunovant, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.2% in the window around the event. It had already run +6.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.